EU Pharma Strategy Offers Window For Regulatory Optimization
‘Very Significant’ Reforms Offer A Chance To Build On Pandemic Experiences
• By David Wallace
Optimizing the regulatory environment in Europe is key for the off-patent industry • Source: Shutterstock